Endoscopic polypectomy in the clinic: A pilot cost-effectiveness analysis

Clinical Otolaryngology

Volumn 41, Issue 2, 2016, Pages 110-117

  Rudmik, L ^a   Smith, K A ^a   Kilty, S ^b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC RHINOSINUSITIS; COMPARATIVE STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; ENDOSCOPIC POLYPECTOMY; ENDOSCOPIC SINUS SURGERY; HUMAN; NOSE OBSTRUCTION; NOSE POLYP; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; SMELLING DISORDER; SYMPTOM; TREATMENT RESPONSE; CANADA; CHRONIC DISEASE; DECISION TREE; ECONOMIC MODEL; ECONOMICS; ENDOSCOPY; MARKOV CHAIN; NASAL POLYPS; RHINITIS; SEVERITY OF ILLNESS INDEX; SINUSITIS;

CANADA; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; DECISION TREES; ENDOSCOPY; HUMANS; MARKOV CHAINS; MODELS, ECONOMIC; NASAL POLYPS; PILOT PROJECTS; QUALITY-ADJUSTED LIFE YEARS; RHINITIS; SEVERITY OF ILLNESS INDEX; SINUSITIS;

EID: 84959317681     PISSN: 17494478     EISSN: 17494486     Source Type: Journal    
DOI: 10.1111/coa.12473     Document Type: Article

References (39)

1. Soler Z.M., Wittenberg E., Schlosser R.J. et al. (2011) Health state utility values in patients undergoing endoscopic sinus surgery. Laryngoscope 121, 2672-2678
2. Rudmik L. & Smith T.L. (2011) Quality of life in patients with chronic rhinosinusitis. Curr. Allergy Asthma Rep. 11, 247-252
3. Rudmik L., Smith T.L., Schlosser R.J. et al. (2014) Productivity costs in patients with refractory chronic rhinosinusitis. Laryngoscope 124, 2007-2012
4. Orlandi R.R., Smith T.L., Marple B.F. et al. (2014) Update on evidence-based reviews with recommendations in adult chronic rhinosinusitis. Int. Forum Allergy Rhinol. 4(Suppl 1), S1-S15
5. Desrosiers M., Evans G.A., Keith P.K. et al. (2011) Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin. Immunol. 7, 2
6. Fokkens W.J., Lund V.J., Mullol J. et al. (2012) EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 50, 1-12
7. Rosenfeld R.M., Piccirillo J.F., Chandrasekhar S.S. et al. (2015) Clinical practice guideline (update): adult sinusitis. Otolaryngol. Head Neck Surg. 152, S1-S39
8. Kilty S.J. (2015) In clinic endoscopic polypectomy for chronic rhinosinusitis with polyps: a treatment strategy pilot study in ten adults. Clin. Otolaryngol. 40(3), 281-284
9. Porter M.E. (2010) What is value in health care? N. Engl. J. Med. 363, 2477-2481
10. Canadian Institute for Health Information (2013) National Health Expenditure Trends, 1975 to 2013- Executive Summary. CIHI, Ottawa, ON
11. Au J. & Rudmik L. (2013) Cost of outpatient endoscopic sinus surgery from the perspective of the Canadian government: a time-driven activity-based costing approach. Int. Forum Allergy Rhinol. 3, 748-754
12. Smith T.L., Litvack J.R., Hwang P.H. et al. (2010) Determinants of outcomes of sinus surgery: a multi-institutional prospective cohort study. Otolaryngol. Head Neck Surg. 142, 55-63
13. Statistics Canada (2012) Life expectancy. URL http://www.statcan.gc.ca/search-recherche/bb/info/life-vie-eng.htm [accessed on 2 January 2015, 2014]
14. Murray C.J., Evans D.B., Acharya A. et al. (2000) Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ. 9, 235-251
15. National Institute of Clinical Excellence (2008) Guide to the methods of technology appraisal. URL http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf [accessed on 1 December 2014]
16. Rudmik L. & Drummond M. (2013) Health economic evaluation: important principles and methodology. Laryngoscope 123, 1341-1347
17. Siegel J.E., Weinstein M.C., Russell L.B. et al. (1996) Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine. JAMA 276, 1339-1341
18. Siebert U., Alagoz O., Bayoumi A.M. et al. (2012) State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med. Decis. Making 32, 690-700
19. Rudmik L., Hoy M., Schlosser R.J. et al. (2013) Topical therapies in the management of chronic rhinosinusitis: an evidence-based review with recommendations. Int. Forum Allergy Rhinol. 3, 281-298
20. Thomas W.W. 3rd, Harvey R.J., Rudmik L. et al. (2013) Distribution of topical agents to the paranasal sinuses: an evidence-based review with recommendations. Int. Forum Allergy Rhinol. 3, 691-703
21. Hopkins C., Gillett S., Slack R. et al. (2009) Psychometric validity of the 22-item Sinonasal Outcome Test. Clin. Otolaryngol. 34, 447-454
22. Smith K.A. & Rudmik L. (2014) Impact of continued medical therapy in patients with refractory chronic rhinosinusitis. Int. Forum Allergy Rhinol. 4, 34-38
23. Soler Z.M., Rudmik L., Hwang P.H. et al. (2013) Patient-centered decision making in the treatment of chronic rhinosinusitis. Laryngoscope 123, 2341-2346
24. Dalziel K., Stein K., Round A. et al. (2006) Endoscopic sinus surgery for the excision of nasal polyps: a systematic review of safety and effectiveness. Am. J. Rhinol. 20, 506-519
25. Hopkins C., Browne J.P., Slack R. et al. (2006) Complications of surgery for nasal polyposis and chronic rhinosinusitis: the results of a national audit in England and Wales. Laryngoscope 116, 1494-1499
26. Hopkins C., Slack R., Lund V. et al. (2009) Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Laryngoscope 119, 2459-2465
27. Ramakrishnan V.R., Kingdom T.T., Nayak J.V. et al. (2012) Nationwide incidence of major complications in endoscopic sinus surgery. Int. Forum Allergy Rhinol. 2, 34-39
28. Rudmik L., Mace J., Soler Z.M. et al. (2014) Long-term utility outcomes in patients undergoing endoscopic sinus surgery. Laryngoscope 124, 19-23
29. Rudmik L., Soler Z.M., Mace J.C. et al. (2015) Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis. Laryngoscope 125, 25-32
30. Stankiewicz J.A., Lal D., Connor M. et al. (2011) Complications in endoscopic sinus surgery for chronic rhinosinusitis: a 25-year experience. Laryngoscope 121, 2684-2701
31. Larsen K. & Tos M. (1997) A long-term follow-up study of nasal polyp patients after simple polypectomies. Eur. Arch. Otorhinolaryngol. 254(Suppl 1), S85-S88
32. Philpott C., Hopkins C., Erskine S. et al. (2015) The burden of revision sinonasal surgery in the UK-data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study. BMJ Open 5, e006680
33. Canadian Vital Statistics (2011) Death database. URL http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=3233 [accessed on 10 May 2015]
34. Drummond M.F., Schulpher M.J., Torrance G.W. et al. (2005) Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford University Press, Oxford, NY
35. Briggs A.H., Weinstein M.C., Fenwick E.A. et al. (2012) Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6. Value Health 15, 835-842
36. Benninger M.S. & Holy C.E. (2014) The impact of endoscopic sinus surgery on health care use in patients with respiratory comorbidities. Otolaryngol. Head Neck Surg. 151, 508-515
37. Bhattacharyya N., Orlandi R.R., Grebner J. et al. (2011) Cost burden of chronic rhinosinusitis: a claims-based study. Otolaryngol. Head Neck Surg. 144, 440-445
38. Shiroiwa T., Sung Y.K., Fukuda T. et al. (2010) International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 19, 422-437
39. Kerr E.A. & Hayward R.A. (2013) Patient-centered performance management: enhancing value for patients and health care systems. JAMA 310, 137-138